About Quidel (NASDAQ:QDEL)
Quidel Corporation is engaged in the development, manufacturing and marketing of diagnostic testing solutions. These diagnostic testing solutions are separated into four product categories: immunoassays, molecular assays, virology and specialty products. The Company sells its products directly to end users and distributors, in each case, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, universities, retail clinics, pharmacies and wellness screening centers. Its diagnostic solutions aid in the detection and diagnosis of critical diseases and other medical conditions, including infectious diseases, women's health, gastrointestinal diseases, autoimmune diseases, bone health and thyroid diseases. The Company provides diagnostic testing solutions under various brand names, including Quidel, QuickVue, QuickVue+, MicroVue, FreshCells, D3 FastPoint, Super E-Mix, ELVIS, Sofia, Quidel Molecular, Amplivue, Lyra and Thyretain.
Industry, Sector and Symbol
Industry Diagnostic substances
Sub-IndustryHealth Care Supplies
SectorMedical
SymbolNASDAQ:QDEL
CUSIP74838J10
Phone858-552-1100
Debt
Debt-to-Equity Ratio1.66%
Current Ratio2.58%
Quick Ratio2.06%
Price-To-Earnings
Trailing P/E Ratio-794.43
Forward P/E Ratio23.37
P/E Growth0.95
Sales & Book Value
Annual Sales$277.74 million
Price / Sales7.46
Cash Flow$1.0676 per share
Price / Cash52.09
Book Value$6.68 per share
Price / Book8.32
Profitability
EPS (Most Recent Fiscal Year)($0.07)
Net Income$-8,160,000.00
Net Margins-2.94%
Return on Equity-3.02%
Return on Assets-1.23%
Miscellaneous
Employees1,193
Outstanding Shares37,280,000
Quidel (NASDAQ:QDEL) Frequently Asked Questions
What is Quidel's stock symbol?
Quidel trades on the NASDAQ under the ticker symbol "QDEL."
How were Quidel's earnings last quarter?
Quidel Co. (NASDAQ:QDEL) released its quarterly earnings results on Wednesday, February, 21st. The company reported $0.56 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of ($0.14) by $0.70. The company had revenue of $114.90 million for the quarter, compared to analysts' expectations of $115.06 million. Quidel had a negative return on equity of 3.02% and a negative net margin of 2.94%. The business's quarterly revenue was up 117.6% compared to the same quarter last year. During the same period in the previous year, the business posted $0.17 earnings per share. View Quidel's Earnings History.
When is Quidel's next earnings date?
What price target have analysts set for QDEL?
8 brokers have issued 12 month price targets for Quidel's shares. Their forecasts range from $47.00 to $64.00. On average, they expect Quidel's stock price to reach $58.50 in the next twelve months. View Analyst Ratings for Quidel.
Are investors shorting Quidel?
Quidel saw a decline in short interest during the month of March. As of March 29th, there was short interest totalling 3,255,890 shares, a decline of 25.6% from the March 15th total of 4,376,368 shares. Based on an average trading volume of 422,117 shares, the days-to-cover ratio is currently 7.7 days. Currently, 10.9% of the shares of the company are short sold.
Who are some of Quidel's key competitors?
Some companies that are related to Quidel include Neogen (NEOG), Immunomedics (IMMU), Myriad Genetics (MYGN), Intellia Therapeutics (NTLA), New England Nuclear (LNTH), Meridian Bioscience (VIVO), Oxford Immunotec Global (OXFD), Nymox Pharmaceutical (NYMX), Quotient (QTNT), Trinity Biotech (TRIB), Celldex Therapeutics (CLDX), Vermillion (VRML), Achieve Life Sciences (ACHV) and BG Medicine (BGMD).
Who are Quidel's key executives?
Quidel's management team includes the folowing people:
- Kenneth F. Buechler Ph.D., Chairman of the Board (Age 63)
- Douglas C. Bryant, President, Chief Executive Officer, Director (Age 59)
- Randall J. Steward, Chief Financial Officer (Age 62)
- Robert Joseph Bujarski J.D., Senior Vice President - Business Development, General Counsel and Corporate Secretary (Age 48)
- Michael D. Abney Jr., Senior Vice President - Distribution (Age 81)
- Werner Kroll Ph.D, Senior Vice President,R&D (Age 60)
- Edward Keith Russell, Senior Vice President - Global Commercial Operations (Age 49)
- Thomas D. Brown, Independent Director (Age 69)
- Mary Lake Polan M.D. Ph.D., Independent Director (Age 73)
- Jack W. Schuler, Independent Director (Age 76)
Has Quidel been receiving favorable news coverage?
News coverage about QDEL stock has trended somewhat positive recently, Accern Sentiment reports. The research firm ranks the sentiment of press coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Quidel earned a coverage optimism score of 0.11 on Accern's scale. They also gave press coverage about the company an impact score of 46.87 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the next few days.
How do I buy shares of Quidel?
Shares of QDEL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Quidel's stock price today?
One share of QDEL stock can currently be purchased for approximately $55.61.
How big of a company is Quidel?
Quidel has a market capitalization of $2.11 billion and generates $277.74 million in revenue each year. The company earns $-8,160,000.00 in net income (profit) each year or ($0.07) on an earnings per share basis. Quidel employs 1,193 workers across the globe.
How can I contact Quidel?
Quidel's mailing address is 12544 HIGH BLUFF DRIVE SUITE 200, SAN DIEGO CA, 92130. The company can be reached via phone at 858-552-1100 or via email at [email protected]
MarketBeat Community Rating for Quidel (QDEL)
MarketBeat's community ratings are surveys of what our community members think about Quidel and other stocks. Vote "Outperform" if you believe QDEL will outperform the S&P 500 over the long term. Vote "Underperform" if you believe QDEL will underperform the S&P 500 over the long term. You may vote once every thirty days.
Quidel (NASDAQ:QDEL) Price Target and Consensus Rating
(How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
8 Wall Street analysts have issued ratings and price targets for Quidel in the last 12 months. Their average twelve-month price target is $58.50, suggesting that the stock has a possible upside of 5.20%. The high price target for QDEL is $64.00 and the low price target for QDEL is $47.00. There are currently 6 buy ratings and 2 strong buy ratings for the stock, resulting in a consensus rating of "Buy."
| Today | 30 Days Ago | 90 Days Ago | 180 Days Ago |
| Consensus Rating: | Buy | Buy | Buy | Buy |
| Consensus Rating Score: | 3.25 | 3.29 | 3.00 | 2.83 |
| Ratings Breakdown: | 0 Sell Rating(s)
0 Hold Rating(s)
6 Buy Rating(s)
2 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
2 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
1 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s) |
| Consensus Price Target: | $58.50 | $54.20 | $50.00 | $47.50 |
| Price Target Upside: | 5.20% upside | 15.61% upside | 11.33% upside | 16.11% upside |
Quidel (NASDAQ:QDEL) Consensus Price Target History
Quidel (NASDAQ:QDEL) Analyst Ratings History
Show:
(Data available from 4/21/2016 forward)
Quidel (NASDAQ:QDEL) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
(Data available from 1/1/2013 forward)
Quidel (NASDAQ QDEL) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 22.00%
Institutional Ownership Percentage: 93.34%
Quidel (NASDAQ QDEL) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 3/29/2018 | Douglas C Bryant | CEO | Sell | 36,000 | $51.63 | $1,858,680.00 | 306,313 |  |
| 3/27/2018 | Douglas C Bryant | CEO | Sell | 12,000 | $51.51 | $618,120.00 | 306,313 | |
| 2/28/2018 | Douglas C Bryant | CEO | Sell | 36,000 | $44.32 | $1,595,520.00 | 302,843 | |
| 2/26/2018 | Douglas C Bryant | CEO | Sell | 12,000 | $44.63 | $535,560.00 | 302,843 | |
| 1/30/2018 | Douglas C Bryant | CEO | Sell | 12,000 | $46.82 | $561,840.00 | 286,493 | |
| 1/22/2018 | Jack W Schuler | Director | Sell | 12,000 | $48.50 | $582,000.00 | | |
| 1/5/2018 | Jack W Schuler | Director | Sell | 4,000 | $47.02 | $188,080.00 | | |
| 1/4/2018 | Ratan S Borkar | SVP | Sell | 29,880 | $45.15 | $1,349,082.00 | 20,253 | |
| 12/29/2017 | Douglas C Bryant | CEO | Sell | 36,000 | $44.10 | $1,587,600.00 | 286,493 | |
| 12/28/2017 | Douglas C Bryant | CEO | Sell | 12,000 | $44.12 | $529,440.00 | 286,493 | |
| 12/27/2017 | Douglas C Bryant | CEO | Sell | 12,000 | $44.50 | $534,000.00 | 286,493 | |
| 12/21/2017 | Jack W Schuler | Director | Sell | 4,000 | $44.60 | $178,400.00 | 3,365,553 | |
| 12/15/2017 | Robert Joseph Bujarski | SVP | Sell | 110,704 | $39.78 | $4,403,805.12 | 79,797 | |
| 12/12/2017 | Randall J Steward | CFO | Sell | 36,383 | $40.09 | $1,458,594.47 | 56,290 | |
| 12/8/2017 | Werner Kroll | SVP | Sell | 16,358 | $40.44 | $661,517.52 | 10,818 | |
| 12/5/2017 | Thomas D Brown | Director | Sell | 12,154 | $39.62 | $481,541.48 | 57,179 | |
| 12/4/2017 | Ratan S Borkar | SVP | Sell | 24,781 | $40.05 | $992,479.05 | 10,811 | |
| 11/30/2017 | Douglas C Bryant | CEO | Sell | 36,000 | $37.36 | $1,344,960.00 | 296,493 | |
| 11/28/2017 | Douglas C Bryant | CEO | Sell | 12,000 | $36.72 | $440,640.00 | 296,493 | |
| 11/9/2017 | Ratan S Borkar | SVP | Sell | 7,965 | $38.91 | $309,918.15 | 11,084 | |
| 11/6/2017 | Werner Kroll | SVP | Sell | 7,565 | $39.50 | $298,817.50 | 10,261 | |
| 10/30/2017 | Douglas C Bryant | CEO | Sell | 12,000 | $41.15 | $493,800.00 | 296,493 | |
| 10/27/2017 | Douglas C Bryant | CEO | Sell | 12,000 | $42.29 | $507,480.00 | 296,493 | |
| 9/29/2017 | Douglas C Bryant | CEO | Sell | 36,000 | $42.91 | $1,544,760.00 | 296,493 | |
| 9/28/2017 | Douglas C Bryant | CEO | Sell | 12,000 | $42.86 | $514,320.00 | 296,493 | |
| 9/27/2017 | Douglas C Bryant | CEO | Sell | 12,000 | $42.17 | $506,040.00 | 296,493 | |
| 8/31/2017 | Douglas C Bryant | CEO | Sell | 36,000 | $34.44 | $1,239,840.00 | 296,493 | |
| 7/31/2017 | Douglas C Bryant | CEO | Sell | 36,000 | $33.83 | $1,217,880.00 | 296,493 | |
| 7/28/2017 | Michael Donald Jr. Abney | SVP | Sell | 1,173 | $33.83 | $39,682.59 | | |
| 7/28/2017 | Randall J Steward | CFO | Sell | 94,215 | $34.09 | $3,211,789.35 | 79,907 | |
| 6/30/2017 | Douglas C Bryant | CEO | Sell | 36,000 | $27.30 | $982,800.00 | 296,493 | |
| 5/31/2017 | Douglas C Bryant | CEO | Sell | 36,000 | $24.98 | $899,280.00 | 296,493 | |
| 5/30/2017 | Douglas C Bryant | CEO | Sell | 12,000 | $25.10 | $301,200.00 | 296,493 | |
| 5/26/2017 | Douglas C Bryant | CEO | Sell | 12,000 | $24.90 | $298,800.00 | 296,493 | |
| 5/2/2017 | Robert Joseph Bujarski | SVP | Sell | 43,225 | $24.27 | $1,049,070.75 | 50,984 | |
| 5/1/2017 | Robert Joseph Bujarski | SVP | Sell | 33,225 | $24.20 | $804,045.00 | 50,984 | |
| 4/28/2017 | Douglas C Bryant | CEO | Sell | 36,000 | $24.16 | $869,760.00 | 296,493 | |
| 3/31/2017 | Douglas C Bryant | CEO | Sell | 37,080 | $22.50 | $834,300.00 | 297,573 | |
| 2/28/2017 | Douglas C. Bryant | CEO | Sell | 106,920 | $21.39 | $2,287,018.80 | | |
| 12/1/2016 | Robert Joseph Bujarski | SVP | Sell | 60,000 | $22.84 | $1,370,400.00 | 74,896 | |
| 11/30/2016 | Douglas C Bryant | CEO | Sell | 72,000 | $22.89 | $1,648,080.00 | 298,011 | |
| 11/29/2016 | Douglas C Bryant | CEO | Sell | 24,000 | $22.84 | $548,160.00 | 298,011 | |
| 11/28/2016 | Douglas C Bryant | CEO | Sell | 24,000 | $23.02 | $552,480.00 | 298,011 | |
| 11/25/2016 | John Tamerius | SVP | Sell | 8,878 | $23.50 | $208,633.00 | 32,418 | |
| 9/30/2016 | Douglas C Bryant | CEO | Sell | 69,168 | $21.76 | $1,505,095.68 | 291,121 | |
| 8/30/2016 | Douglas C Bryant | CEO | Sell | 2,832 | $22.00 | $62,304.00 | 276,843 | |
| 8/9/2016 | Robert Joseph Bujarski | SVP | Sell | 22,057 | $22.58 | $498,047.06 | 60,100 | |
| 8/1/2016 | John Tamerius | SVP | Sell | 7,000 | $23.02 | $161,140.00 | 18,540 | |
| 2/19/2016 | Douglas C. Bryant | CEO | Buy | 3,700 | $13.91 | $51,467.00 | | |
| 12/2/2015 | John Tamerius | SVP | Sell | 21,109 | $21.95 | $463,342.55 | 26,854 | |
| 10/30/2015 | Douglas C Bryant | CEO | Buy | 20,000 | $19.76 | $395,200.00 | 249,404 | |
| 10/3/2014 | John Tamerius | SVP | Sell | 5,000 | $28.00 | $140,000.00 | | |
| 9/18/2014 | John Tamerius | SVP | Sell | 10,000 | $26.50 | $265,000.00 | | |
| 7/24/2014 | Douglas C Bryant | CEO | Buy | 20,000 | $24.12 | $482,400.00 | | |
| 7/23/2014 | John Tamerius | SVP | Sell | 15,000 | $24.50 | $367,500.00 | | |
| 6/24/2014 | John Tamerius | SVP | Sell | 5,000 | $23.06 | $115,300.00 | | |
| 2/26/2014 | John Tamerius | SVP | Sell | 47,246 | $27.69 | $1,308,241.74 | 32,019 | |
| 2/13/2014 | Rodney Dammeyer | Director | Sell | 26,000 | $27.70 | $720,200.00 | | |
| 10/29/2013 | Mark Pulido | Director | Sell | 12,750 | $25.31 | $322,702.50 | | |
| 5/29/2013 | Robert Joseph Bujarski | SVP | Sell | 28,808 | $23.16 | $667,193.28 | | |
| 5/17/2013 | Robert Joseph Bujarski | SVP | Sell | 27,479 | $23.12 | $635,314.48 | | |
(Data available from 1/1/2013 forward)
Quidel (NASDAQ QDEL) News Headlines
| Source: |
|
Quidel (NASDAQ:QDEL) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Quidel (NASDAQ:QDEL) Income Statement, Balance Sheet and Cash Flow Statement
Quidel (NASDAQ QDEL) Stock Chart for Saturday, April, 21, 2018
Loading chart…
